biochemical and physiological changes, which frequently influence the outcome of
anticancer therapies. The biochemical rationale behind many of these phenomena resides
in the activation of transcription factors such as hypoxia-inducible factor 1 and 2 (HIF-1/2). In
turn, the HIF pathway activates a number of genes including those involved in glucose
metabolism, angiogenesis, and pH regulation. Several carbonic anhydrase (CA, EC 4.2. 1.1) …